Monoclonal Antibody to MART-1 / Melan-A / MLANA (Melanoma Marker)(A103 + M2-7C10 + M2-9E3), Clone: [A103 + M2-7C10 + M2-9E3], Mouse

Artikelnummer: ABI-36-1133
Artikelname: Monoclonal Antibody to MART-1 / Melan-A / MLANA (Melanoma Marker)(A103 + M2-7C10 + M2-9E3), Clone: [A103 + M2-7C10 + M2-9E3], Mouse
Artikelnummer: ABI-36-1133
Hersteller Artikelnummer: 36-1133
Alternativnummer: ABI-36-1133-100UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF, IHC, WB
Spezies Reaktivität: Human, Mouse, Rat
Immunogen: Recombinant hMART-1 protein (A103, M2-7C10, M2-9E3)
Alternative Synonym: MLANA||MART1
This antibody recognizes a protein doublet of 20-22kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb cocktail labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
Klonalität: Monoclonal
Klon-Bezeichnung: [A103 + M2-7C10 + M2-9E3]
NCBI: 2315
UniProt: Q16655
Reinheit: Affinity Chromatography
Formulierung: Purified
Target-Kategorie: MART-1 / Melan-A / MLANA (Melanoma Marker)
Application Verdünnung: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml), Western Blot (1-2ug/ml), Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM E